Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Enrico TORRE"'
Autor:
Enrico Torre, Giacomo Matteo Bruno, Sergio Di Matteo, Chiara Martinotti, Maria Chiara Valentino, Luigi Carlo Bottaro, Giorgio Lorenzo Colombo
Publikováno v:
Health Services Insights, Vol 13 (2020)
Diabetes treatment cost represents an ever-growing problem. The adoption of new drugs in therapy, although they can guarantee an improvement in patient’s quality of life, can meet obstacles when it involves an increase in costs. We decided to compa
Externí odkaz:
https://doaj.org/article/eee1f02fc8ec485ca0ed251f2a8b2131
Publikováno v:
Global & Regional Health Technology Assessment, Vol 2, Iss 3 (2015)
Externí odkaz:
https://doaj.org/article/15ef0c72634c4e2681a8ac332866fd54
Autor:
Enrico Torre, Sergio Di Matteo, Giacomo Matteo Bruno, Chiara Martinotti, Maria Chiara Valentino, Gianni Testino, Alberto Rebora, Luigi Carlo Bottaro, Giorgio Lorenzo Colombo
Publikováno v:
ClinicoEconomics and Outcomes Research. 14:607-618
Enrico Torre,1 Sergio Di Matteo,2 Giacomo Matteo Bruno,3 Chiara Martinotti,2 Maria Chiara Valentino,2 Gianni Testino,4 Alberto Rebora,1 Luigi Carlo Bottaro,5 Giorgio Lorenzo Colombo3 1Diabetology and Metabolic Diseases Unit - ASL3, Genoa, Italy; 2S.A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff66d97d720c0179fbe87271def74b71
https://doi.org/10.2147/ceor.s371778
https://doi.org/10.2147/ceor.s371778
Autor:
Lorenzo SAMPIETRO, Monica CIRONE, Luca LIONE, Davide GONELLA, Gianni TESTINO, Luigi C. BOTTARO, Enrico TORRE
Publikováno v:
Minerva Endocrinology. 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95fc8e2863990c446486cff78600cad4
https://doi.org/10.23736/s2724-6507.23.03994-5
https://doi.org/10.23736/s2724-6507.23.03994-5
Autor:
Gianni TESTINO, Luigi C. BOTTARO, Enzo ANDORNO, Fabio BANDINI, Patrizia BALBINOT, Sabrina BELTRAMINI, Simona BOTTINO, Marta CALTABELLOTTA, Fabio CAPUTO, Enrica CAVIGLIA, Pierfrancesco CURONE, Antonio DI BIAGIO, Carmelo GAGLIANO, Nicoletta GANDOLFO, Luca PESTARINO, Alessandro ROLLERO, Emanuele ROMAIRONE, Lorenzo SAMPIETRO, Enrico TORRE, Silvia ZUCCARELLI, Rinaldo PELLICANO
Publikováno v:
Minerva Medica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::707c905e85fec9e2a36b8be3658d6817
https://doi.org/10.23736/s0026-4806.22.08408-7
https://doi.org/10.23736/s0026-4806.22.08408-7
Autor:
Francesca Cecoli, Paolo Di Bartolo, Enrico Torre, Chiara Martinotti, MC Valentino, Eleonora Monti, Marco Galimberti, Giorgio Colombo, Alberto Rebora, GM Bruno, Sergio Di Matteo, Germano Gaggioli
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Enrico Torre,1 Giorgio Lorenzo Colombo,2 Sergio Di Matteo,3 Chiara Martinotti,3 Maria Chiara Valentino,3 Alberto Rebora,1 Francesca Cecoli,1 Eleonora Monti,1 Marco Galimberti,4 Paolo Di Bartolo,5 Germano Gaggioli,6 Giacomo Matteo Bruno2 1Endocrinolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed3085084485141258471c621b9a01d
https://doi.org/10.2147/ceor.s313577
https://doi.org/10.2147/ceor.s313577
Publikováno v:
Minerva Medica. 113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb2a2e9541864a55af8eb0cc2b4a4a5
https://doi.org/10.23736/s0026-4806.22.08019-3
https://doi.org/10.23736/s0026-4806.22.08019-3
Autor:
GM Bruno, MC Valentino, Sergio Di Matteo, Giorgio Colombo, Enrico Torre, Luigi Carlo Bottaro, Chiara Martinotti
Publikováno v:
ClinicoEconomics and Outcomes Research. 12:177-189
Background Diabetes represents a relevant public health problem worldwide due to its growing prevalence and socioeconomic burden, principally due to the development of macrovascular and microvascular complications as well as to the continuous launch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6567f3d03809c211cbe01c134c2dc69
https://doi.org/10.2147/ceor.s240183
https://doi.org/10.2147/ceor.s240183
Publikováno v:
Diabetes/Metabolism Research and Reviews
Despite the importance of individualised strategies for patients with type 2 diabetes mellitus (T2DM) and the availability of alternative treatments, including glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), sulphonylureas are still wide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1a91058c3442b0219a747646cbca91
https://pubmed.ncbi.nlm.nih.gov/33900667
https://pubmed.ncbi.nlm.nih.gov/33900667